insights_auto
Pourquoi CRSP a-t-elle augmenté de 3,57%?
Approfondirchevron_right
CRSP:NASDAQ
Crispr Therapeutics AG
51,78 $US
arrow_upward
+3,57%(+1,78) 1J
51,78 $US
arrow_upward
+0,01% (+0,0050)todayAvant ouverture
Fermé : 4 nov., 16:00:00 UTC−5 · USD
search
Tous les symboles
| Symbole | Cours | Variation | % variat. |
|---|
insights_autoGénération des principaux insights pour CRSP...
Ouverture
51,48 $US
Élevé
52,50 $US
Faible
50,19 $US
Cap. boursière
5,02 Md
Vol. moyen
1,47 M
Volume
1,70 k
+ haut sur 1 an
63,45 $US
+ bas sur 1 an
44,12 $US
BPA
-4,75 $US
Bêta
1,49
Actions en circulation
97,00 M
Nombre d'employés
393
Ouverture
51,48 $US
Élevé
52,50 $US
Faible
50,19 $US
Cap. boursière
5,02 Md
Vol. moyen
1,47 M
Volume
1,70 k
+ haut sur 1 an
63,45 $US
+ bas sur 1 an
44,12 $US
BPA
-4,75 $US
Bêta
1,49
Actions en circulation
97,00 M
Nombre d'employés
393
Articles
Sources : Web et partenaires du secteur de l'information
GuruFocus
·
il y a 17 heures
CRSP Maintains Equal-Weight by Wells Fargo -- Price Target Lowered to $70
Investing.com
·
il y a 23 heures
Wells Fargo cuts CRISPR Therapeutics stock price target on earnings
Yahoo Finance
·
il y a 1 jour
CRISPR Therapeutics (CRSP) Stock Looks Fully Valued As It Names A New CTO
Zacks
·
il y a 1 jour
CRSP's Q3 Loss Wider Than Expected, Sales Beat Estimates
Profil
CRISPR Therapeutics AG is a Swiss–American biotechnology company headquartered in Zug, Switzerland. The company does business as CRISPR Therapeutics, Inc. in the United States. It was one of the first companies formed to utilize the CRISPR gene editing platform to develop medicines for the treatment of various rare and common diseases. The company has approximately 500 employees and has offices in Zug, Switzerland; Boston, Massachusetts; San Francisco, California; and London, United Kingdom. Its manufacturing facility in Framingham, Massachusetts, won the Facilities of the Year Award award in 2022. The company’s lead program, exagamglogene autotemcel, or exa-cel, was granted regulatory approval by the US Food and Drug Administration in December 2023. Wikipedia
À propos de Crispr Therapeutics AG
PDGSamarth Kulkarni
Employés393
Date de création2013
Siège socialZoug, Zoug, Suisse
Secteur-
Industry-
Site Webcrisprtx.com